Completed A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation NCT02659735 Conditions Influenza A Virus Locations Antwerp, Belgium View Trial Details
Completed A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection NCT02532283 Conditions Influenza A Virus Locations Fresno, California, United States Long Beach, California, United States Stanford, California, United States Atlantis, Florida, United States View all 68 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Safety Study of Avian Flu Vaccine NCT00408109 Conditions Animal Diseases, Bird Diseases, H5N1 Virus, +9 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
Completed Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally NCT00489931 Conditions Animal Diseases, Bird Diseases, H5N1 Virus, +9 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
